Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Trends in Pharmacological Sciences
|
February 1, 1994
New dawn of cannabinoid pharmacology
W A Devane
Proceedings of the National Academy of Sciences of the United States of America
|
July 5, 1994
Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes
W A Devane, J Axelrod
Molecular Pharmacology
|
September 1, 1993
Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells
K Mackie, W A Devane, B Hille
Pharmacology, Biochemistry, and Behavior
|
November 1, 1991
A random walk through a cannabis field
R Mechoulam, W A Devane, A Breuer, et al.
Journal of Neurochemistry
|
July 1, 1990
Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain
M Bidaut-Russell, W A Devane, A C Howlett
Farmaco (Societa Chimica Italiana : 1989)
|
January 1, 1991
Nonpsychotropic synthetic cannabinoids as therapeutic agents
R Mechoulam, A Breuer, J J Feigenbaum, et al.
Journal of Neurochemistry
|
June 1, 1986
An assessment of the role of opioid receptors in the response to cannabimimetic drugs
W A Devane, J W Spain, C J Coscia, et al.
Molecular Pharmacology
|
November 1, 1988
Determination and characterization of a cannabinoid receptor in rat brain
W A Devane, F A Dysarz, M R Johnson, et al.
Molecular Pharmacology
|
August 1, 1995
Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors
J Priller, E M Briley, J Mansouri, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 24, 1995
Long-term synaptic transformation of hippocampal CA1 gamma-aminobutyric acid synapses and the effect of anandamide
C Collin, W A Devane, D Dahl, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Trends in Pharmacological Sciences
|
February 1, 1994
New dawn of cannabinoid pharmacology
W A Devane
Proceedings of the National Academy of Sciences of the United States of America
|
July 5, 1994
Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes
W A Devane, J Axelrod
Molecular Pharmacology
|
September 1, 1993
Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells
K Mackie, W A Devane, B Hille
Pharmacology, Biochemistry, and Behavior
|
November 1, 1991
A random walk through a cannabis field
R Mechoulam, W A Devane, A Breuer, et al.
Journal of Neurochemistry
|
July 1, 1990
Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain
M Bidaut-Russell, W A Devane, A C Howlett
Farmaco (Societa Chimica Italiana : 1989)
|
January 1, 1991
Nonpsychotropic synthetic cannabinoids as therapeutic agents
R Mechoulam, A Breuer, J J Feigenbaum, et al.
Journal of Neurochemistry
|
June 1, 1986
An assessment of the role of opioid receptors in the response to cannabimimetic drugs
W A Devane, J W Spain, C J Coscia, et al.
Molecular Pharmacology
|
November 1, 1988
Determination and characterization of a cannabinoid receptor in rat brain
W A Devane, F A Dysarz, M R Johnson, et al.
Molecular Pharmacology
|
August 1, 1995
Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors
J Priller, E M Briley, J Mansouri, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 24, 1995
Long-term synaptic transformation of hippocampal CA1 gamma-aminobutyric acid synapses and the effect of anandamide
C Collin, W A Devane, D Dahl, et al.
Page
of 2